In summary, we believe we have shown that tyrosine kinase-independent actions of DDR2 in breast tumor cells and breast tumor CAFs contribute to metastatic regulation of breast cancer, in particular through regulation of the secretome (i.e. paracrine regulation). This evidence concerns the gene DDR2 and breast neoplasm.